# Bonk, Inc.: overview BNKK · Nasdaq · CIK 1760903 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bnkk.md) · [Financials](/companies/bnkk/financials.md) · [Filings](/companies/bnkk/filings.md) · [Insiders](/companies/bnkk/insiders.md) Latest reported revenue: [$792.9k](/filings/0001493152-26-038241.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-038241). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [110](/filings/0001493152-25-024307.md) | [182 d](/filings/0001493152-26-014015.md) | [42.1](/filings/0001493152-26-022743.md) | [44.9](/filings/0001493152-26-038241.md) | [1,515](/filings/0001493152-25-024307.md) | [515 d](/filings/0001493152-26-014015.md) | [786](/filings/0001493152-26-022743.md) | [793](/filings/0001493152-26-038241.md) | | Gross margin | % | [(265.1%)](/filings/0001493152-25-024307.md) | [(228.6%) d](/filings/0001493152-26-014015.md) | [49.9%](/filings/0001493152-26-022743.md) | [53.1%](/filings/0001493152-26-038241.md) | [35.9%](/filings/0001493152-25-024307.md) | [126.1% d](/filings/0001493152-26-014015.md) | [456.9%](/filings/0001493152-26-022743.md) | [49.3%](/filings/0001493152-26-038241.md) | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(10823.8%)](/filings/0001493152-25-024307.md) | [(7427.8%) d](/filings/0001493152-26-014015.md) | [(12652.7%)](/filings/0001493152-26-038241.md) | [29756.5%](/filings/0001493152-26-038241.md) | [(2216.8%)](/filings/0001493152-25-024307.md) | [(8274.9%) d](/filings/0001493152-26-014015.md) | [(232.6%)](/filings/0001493152-26-038241.md) | [(763.6%)](/filings/0001493152-26-038241.md) | | Diluted EPS | $ per share | [(0.21)](/filings/0001493152-24-045990.md) | not reported | [(0.08)](/filings/0001641172-25-010835.md) | [3.12](/filings/0001493152-26-038241.md) | not reported | not reported | not reported | [(0.76)](/filings/0001493152-26-038241.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2.9](/filings/0001493152-23-010480.md) | [0.1](/filings/0001493152-24-012476.md) | [0.2](/filings/0001641172-25-001259.md) | [0.7](/filings/0001493152-26-014015.md) | [2.1](/filings/0001493152-26-014015.md) | | Gross margin | % | [18.6%](/filings/0001493152-23-010480.md) | [(169.6%)](/filings/0001493152-24-012476.md) | [(36.7%)](/filings/0001641172-25-001259.md) | [(348.4%)](/filings/0001493152-26-014015.md) | [58.5%](/filings/0001493152-26-014015.md) | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(977.0%)](/filings/0001493152-23-010480.md) | [(12619.9%)](/filings/0001493152-24-012476.md) | [(7442.2%)](/filings/0001641172-25-001259.md) | [(7038.7%)](/filings/0001493152-26-014015.md) | [(3220.4%)](/filings/0001493152-26-014015.md) | | Diluted EPS | $ per share | [(1.69)](/filings/0001493152-23-010480.md) | [(0.69)](/filings/0001493152-24-012476.md) | [(0.49)](/filings/0001641172-25-001259.md) | [(31.77)](/filings/0001493152-26-014015.md) | [(17.02)](/filings/0001493152-26-014015.md) | | Free cash flow | $m | [(6.6)](/filings/0001493152-24-001400.md) | [(6.5)](/filings/0001493152-24-001400.md) | [(10.6)](/filings/0001493152-24-045990.md) | [(18.2)](/filings/0001641172-25-010835.md) | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bnkk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $177.9k | 117,020 | | New +117,020 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $159.2k | 104,761 | | Added +16,235 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $145.3k | 95,620 | | Unchanged | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $77.9k | 51,275 | | New +51,275 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $77.0k | 50,658 | | Reduced −9,603 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $50.4k | 33,188 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $35.8k | 23,545 | | New +23,545 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $34.2k | 22,528 | | Unchanged | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $19.6k | 12,925 | | New +12,925 | | [TWO SIGMA SECURITIES, LLC](/funds/1450144.md) | 2026-06-30 | $19.5k | 12,801 | | New +12,801 | ## Recent filings [All 603 filings](/companies/bnkk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-11 | 16:45 ET | [8-K](/filings/0001493152-26-042401.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042401 | | 2026-08-14 | 15:01 ET | [10-Q](/filings/0001493152-26-038241.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038241 | | 2026-05-13 | 16:24 ET | [10-Q](/filings/0001493152-26-022743.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022743 | | 2026-04-30 | 18:25 ET | [8-K](/filings/0001493152-26-019685.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-019685 | | 2026-04-28 | 17:27 ET | [8-K](/filings/0001493152-26-019410.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-019410 | | 2026-03-31 | 14:20 ET | [10-K](/filings/0001493152-26-014015.md) | Annual report, period 2025-12-31 | 0001493152-26-014015 | | 2026-01-28 | 16:58 ET | [S-1/A](/filings/0001493152-26-004051.md) | Registration statement, amended | 0001493152-26-004051 | | 2026-01-14 | 15:46 ET | [8-K](/filings/0001493152-26-002247.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-002247 | | 2026-01-05 | 14:35 ET | [8-K](/filings/0001493152-26-000339.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-000339 | | 2025-12-29 | 16:49 ET | [8-K](/filings/0001493152-25-029401.md) | 5.07 Shareholder vote results | 0001493152-25-029401 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014015.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bbeb1a29-0de7-47b6-a7cd-9ff16e97af98) ## About the filer - CIK: 1760903 - Tickers: BNKK - Exchange: Nasdaq - SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 15:31 ET. No prices; not investment advice.